is bydureon a glp 1 The FDA Declines to Approve Bydureon, New Once-Weekly GLP-1 Agonist AstraZeneca's Bydureon gets a facelift,

10.4161/cc.8.23.10068 Cell Cycle

SDP has received research funding from AstraZeneca, Boehringer Ingelheim, Novartis Pharmaceuticals Co., and Merck Sharpe & Dohme, and is a consultant for or has received honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceuticals, Laboratoires Servier, Merck Sharp & Dohme, Novartis Pharmaceuticals Co., Novo Nordisk, Sanofi, and Takeda

PMID 25751285

329 NelsonMJBahlJSBuckleyJDThomsonRLDavisonK

PROMOTES MEMORY & FOCUS KEY COMPONENTS OF MENTAL CLARITY: Qunol Brain Health Memory Plus combines Magtein Magnesium L-Threonate and Cognizin Citicoline to help improve memory, focus, attention, and productivity

Pigment Cell Res (2004) 17(3):28994